KSKarl Heinz Scheidtmann

Karl Heinz Scheidtmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karl Heinz Scheidtmann has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterization of rat BLOS2/Ceap, a putative yeast She3 homolog, as interaction partner of apoptosis antagonizing transcription factor/Che-1

    by Andrea Felten, Peter Leister, Sven Burgdorf, Lutz Uhlmann, Karl Heinz Scheidtmann

    AATF/Che-1 is a coactivator of several transcription factors, including steroid hormone receptors. In search of novel interaction partners of AATF, we identified BLOS2 (BLOC1S2, also termed Ceap) from a rat cDNA library. BLOS2 is extremely conserved with a high degree of homology to yeast She3p. The clone isolated represents a splice variant encoding a polypeptide of 168 residues. Rat BLOS2 mRNA is highly expressed in brain and testis and at lower levels in other tissues, but not in skeletal or smooth muscle. Expression as a tagged fusion protein revealed predominant cytoplasmic, but also nuclear localization. In the cytoplasm, BLOS2 fusion proteins exhibit diffuse, filamentous, or dotted distribution, with the latter partially co-localizing with recycling endosomes. In addition, BLOS2 localizes to centrosomes or the pericentrosomal region. Moreover, BLOS2 co-localizes with myosin V globular tail domains in vesicle-like structures. However, a direct interaction could not be demonstrated. In transactivation assays, BLOS2 enhanced transcription from androgen receptor and p53-responsive promoters. However, this enhancement correlated with accumulation of both androgen receptor and p53, suggesting that BLOS2 has a stabilizing effect on these transcription factors. We propose that BLOS2 functions as an adapter in processes such as protein and vesicle processing and transport, and perhaps transcription.


  • Apoptosis antagonizing transcription factor AATF is a novel coactivator of nuclear hormone receptors

    by Peter Leister, Sven Burgdorf, Karl Heinz Scheidtmann

    Apoptosis antagonizing transcription factor AATF was identified as interaction partner of Dlk/ZIP kinase and shown to exhibit transactivation activity in Gal4‐based reporter gene expression assays. The human ortholog Che‐1 was independently isolated as interacting protein of RNA polymerase II suggesting that AATF might be a transcriptional adapter or mediator which serves to link transcriptional activators to the general transcription machinery. Consistent with this assumption, AATF contains several interaction motifs including a leucine zipper and three putative binding motifs for nuclear hormone receptors. In this study, we investigated a possible functional relationship of AATF to nuclear receptors. Indeed, AATF enhanced transactivation by several steroid hormone receptors including androgen, estrogen and glucocorticoid receptors in a hormone‐dependent manner. This enhancing effect was further increased by p300 but not by a mutant of p300 lacking acetyl transferase activity. AATF bound directly to the receptors in vitro. Co‐activation was impaired with AATF mutants bearing mutations in the LXXLL NR binding motifs. Our data suggest that AATF is a novel coactivator of nuclear hormone receptors.


  • Open Access

    Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase

    by Ute Preuss, Gerd Landsberg, Karl Heinz Scheidtmann

    Death‐associated protein (DAP)‐like kinase (Dlk), also known as Zipper interacting protein (ZIP) kinase, is a nuclear serine/threonine‐specific kinase that phosphorylates core histones H3 and H4, and myosine light chain in vitro. It interacts with transcription and splicing factors as well as with pro‐apoptotic protein Par‐4 suggesting that it participates in multiple cellular processes. To explore the significance of histone phosphorylation by Dlk, we determined the phosphorylation site in H3 and generated phosphospecific antibodies for in vivo analyses. Interestingly, Dlk/ZIP kinase phosphorylated histone H3 at a novel site, Thr11, rather than Ser10, which is characteristic of mitotic chromosomes. Immunoblotting and confocal immunofluorescence analyses demonstrated that phosphoryl ation of H3 at Thr11 occurred in vivo and was restricted to mitosis as well. It was discernable from prophase to early anaphase and particularly enriched at centromeres. Strikingly, during this time interval, Dlk was associated with centromeres too, as revealed by stable expression of a green fluorescent protein (GFP)‐Dlk fusion protein. These findings strongly suggest that Dlk is a centromere‐specific histone kinase that might play a role in labeling centromere‐specific chromatin for subsequent mitotic processes.